Xponance’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $890K | Sell |
8,383
-211
| -2% | -$22.4K | 0.01% | 735 |
|
2025
Q1 | $1.07M | Buy |
8,594
+648
| +8% | +$80.4K | 0.01% | 670 |
|
2024
Q4 | $979K | Buy |
7,946
+1,195
| +18% | +$147K | 0.01% | 731 |
|
2024
Q3 | $752K | Sell |
6,751
-23
| -0.3% | -$2.56K | 0.01% | 804 |
|
2024
Q2 | $723K | Sell |
6,774
-6,418
| -49% | -$685K | 0.01% | 785 |
|
2024
Q1 | $1.59M | Buy |
13,192
+2,590
| +24% | +$312K | 0.02% | 580 |
|
2023
Q4 | $1.3M | Sell |
10,602
-346
| -3% | -$42.6K | 0.02% | 584 |
|
2023
Q3 | $1.42M | Sell |
10,948
-203
| -2% | -$26.3K | 0.02% | 551 |
|
2023
Q2 | $1.38M | Buy |
11,151
+2,782
| +33% | +$345K | 0.02% | 558 |
|
2023
Q1 | $1.22M | Buy |
8,369
+36
| +0.4% | +$5.27K | 0.02% | 585 |
|
2022
Q4 | $1.33M | Buy |
8,333
+957
| +13% | +$152K | 0.02% | 548 |
|
2022
Q3 | $983K | Sell |
7,376
-93
| -1% | -$12.4K | 0.02% | 585 |
|
2022
Q2 | $1.17M | Buy |
7,469
+598
| +9% | +$93.3K | 0.02% | 528 |
|
2022
Q1 | $1.07M | Sell |
6,871
-52
| -0.8% | -$8.1K | 0.02% | 574 |
|
2021
Q4 | $882K | Sell |
6,923
-17
| -0.2% | -$2.17K | 0.01% | 659 |
|
2021
Q3 | $904K | Sell |
6,940
-193
| -3% | -$25.1K | 0.02% | 609 |
|
2021
Q2 | $1.27M | Buy |
7,133
+1,171
| +20% | +$208K | 0.02% | 492 |
|
2021
Q1 | $980K | Buy |
5,962
+85
| +1% | +$14K | 0.02% | 486 |
|
2020
Q4 | $970K | Sell |
5,877
-6
| -0.1% | -$990 | 0.02% | 476 |
|
2020
Q3 | $839K | Buy |
+5,883
| New | +$839K | 0.02% | 468 |
|